生物
病毒学
冠状病毒
猿猴免疫缺陷病毒
病毒
逆转录病毒
HEK 293细胞
病毒目
病毒进入
糖蛋白
小鼠白血病病毒
细胞培养
分子生物学
病毒复制
2019年冠状病毒病(COVID-19)
遗传学
病理
传染病(医学专业)
医学
疾病
作者
Michael J. Moore,Tatyana Dorfman,Wenhui Li,Swee Kee Wong,Yanhan Li,Jens H. Kuhn,James A. Coderre,Natalya Vasilieva,Zhongchao Han,Thomas C. Greenough,Michael Farzan,Hyeryun Choe
出处
期刊:Journal of Virology
[American Society for Microbiology]
日期:2004-09-14
卷期号:78 (19): 10628-10635
被引量:277
标识
DOI:10.1128/jvi.78.19.10628-10635.2004
摘要
Infection of receptor-bearing cells by coronaviruses is mediated by their spike (S) proteins. The coronavirus (SARS-CoV) that causes severe acute respiratory syndrome (SARS) infects cells expressing the receptor angiotensin-converting enzyme 2 (ACE2). Here we show that codon optimization of the SARS-CoV S-protein gene substantially enhanced S-protein expression. We also found that two retroviruses, simian immunodeficiency virus (SIV) and murine leukemia virus, both expressing green fluorescent protein and pseudotyped with SARS-CoV S protein or S-protein variants, efficiently infected HEK293T cells stably expressing ACE2. Infection mediated by an S-protein variant whose cytoplasmic domain had been truncated and altered to include a fragment of the cytoplasmic tail of the human immunodeficiency virus type 1 envelope glycoprotein was, in both cases, substantially more efficient than that mediated by wild-type S protein. Using S-protein-pseudotyped SIV, we found that the enzymatic activity of ACE2 made no contribution to S-protein-mediated infection. Finally, we show that a soluble and catalytically inactive form of ACE2 potently blocked infection by S-protein-pseudotyped retrovirus and by SARS-CoV. These results permit studies of SARS-CoV entry inhibitors without the use of live virus and suggest a candidate therapy for SARS.
科研通智能强力驱动
Strongly Powered by AbleSci AI